Talphera Advances Key Drug Candidate Toward Regulatory Submission
Talphera has achieved a significant enrollment milestone for its lead investigational drug, Niyad. The company announced that patient recruitment for ...
Tag: Talphera
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
